Search Results
Jun 09, 2026, 03:09 ET Implantica announces launch of 20th RefluxStop® Center of Excellence in Spain, part of a world-renowned US hospital group
part of the world-renowned U.S. hospital group MD Anderson Cancer group. The RefluxStop® procedure was performed by Oscar Alonso MD, PhD, GI Surgical Oncologist and Head of Robotic Gastrointestinal Surgery at MD Anderson Cancer Center Madrid-Hospiten, marking the 20th RefluxStop® center
More news about: Implantica
Jun 08, 2026, 16:10 ET Visage Highlights One Platform AI-Optimized at SIIM26
innovations as the AI ecosystem continues to evolve."Visage 7 | Reporting represents an exciting milestone for Visage 7," said Malte Westerhoff, PhD, Visage Co-Founder and Global Chief Technology Officer. "By delivering, native, AI optimized reporting directly with One Platform, we are eliminating
More news about: Visage Imaging, Inc.
Jun 08, 2026, 15:06 ET Leading Physician-Economist Dr. Amol Navathe Appointed Chair of the Medicare Payment Advisory Commission (MedPAC)
June 8, 2026 /PRNewswire/ -- The U.S. Government Accountability Office (GAO) has officially announced the appointment of Amol Navathe, MD, PhD, as the new Chair of the Medicare Payment Advisory Commission (MedPAC). Navathe is a prominent internal medicine physician and leading national scholar
More news about: Dr. Amol Navathe
Jun 08, 2026, 14:30 ET ACHIEVE Trials Demonstrate Comparative Benefits of Novel, Small-Molecule Oral GLP-1 RA, Expanding Oral Treatment Options for Patient Population in Need of Alternative Solutions
for people with type 2 diabetes who are already managing complex treatment routines, including basal insulin," said Professor Francesco Giorgino, MD, PhD, lead author of the study. "For many patients, basal insulin alone is not enough to maintain glycemic control, and an oral GLP-1 therapy
More news about: American Diabetes Association
Jun 08, 2026, 14:27 ET Bonnie Johnson, PhD, FAICP, Named Book Review Editor of Journal of the American Planning Association (JAPA)
Bonnie J. Johnson, PhD, FAICP, assistant director of the School of Public Affairs and Administration and professor of urban planning at the University of Kansas, has joined
More news about: American Planning Association
Jun 08, 2026, 11:30 ET Age Limits Alone Won't Fix Smartphone Risks, Suggests Children's Hospital of Philadelphia Study
Ran Barzilay, MD, PhD, the study's senior author and a child-psychiatrist with the
More news about: Children's Hospital of Philadelphia
Jun 08, 2026, 09:15 ET Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution
nervous system tumors. The team was led by Richard Mair, PhD, a neurosurgeon at Addenbrooke's Hospital and a University of Cambridge scientist, in collaboration with the Spatial Profiling Annotation Centre of Excellence (SPACE) led by Dario Bressan, PhD. The team evaluated glioma and glioblastoma tissues to
More news about: Illumina, Inc.
Jun 08, 2026, 08:57 ET RNR Tire Express Awards Three Brand New Cars to Deserving Mothers for 10th Annual Mother's Day Giveaway
emotional behavior disorders, working with students ages 3 to 22. She recently wrote a children's book for children with autism and is pursuing her PhD in behavioral neuroscience.Brown, who was joined by her family, was surprised by the RNR team with her brand-new 2026 Buick Envista at the RNR
More news about: RNR Tire Express
Jun 08, 2026, 08:15 ET Lennox-Gastaut Syndrome (LGS) Foundation Launches Pre-Competitive Research Accelerator for LGS and Associated Developmental and Epileptic Encephalopathies
problems no single organization can solve alone, including inconsistent endpoints and the lack of a shared evidence base," said Tracy Dixon-Salazar, PhD, President and CEO of the LGS Foundation. "The Accelerator gives the community a place to fix those barriers together, so the science moves faster
More news about: Lennox-Gastaut Syndrome (LGS) Foundation
Jun 08, 2026, 08:04 ET TransCode Therapeutics to Host R&D Webcast on June 18, 2026
Advisory BoardPhilippe P Calais, PharmD, PhD — Chief Executive Officer and Chairman of the Board, TransCode TherapeuticsDan Vlock, MD — Consulting Oncology Clinician, TransCode TherapeuticsZdravka Medarova, PhD — Co-Founder and Chief Scientific Officer, TransCode
More news about: TransCode Therapeutics, Inc.
Jun 08, 2026, 08:00 ET Dario Presents Four Studies at American Diabetes Association Scientific Sessions Highlighting Commercial and Clinical Value of its Digital Health Platform
than a fragmented set of point solutions.""What stands out across all four studies is the consistency of the signal," said Yifat Hershcovitz, PhD, VP Clinical & Scientific Affairs at Dario. "Whether the focus is utilization, weight or glycemic control, the data show that members who stay meaningfully
More news about: DarioHealth Corp.
Jun 08, 2026, 07:30 ET Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
for proposal for vaccine development for Bundibugyo virus (BDBV) with applications due June 12, 2026. Soligenix, in collaboration with Axel Lehrer, PhD, Professor in the Department of Tropical Medicine, Medical Microbiology and Pharmacology at the John A. Burns School of Medicine, University of Hawaiʻi
More news about: SOLIGENIX, INC.
Jun 08, 2026, 05:00 ET Foresee's Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson's Disease in the SLEIPNIR Phase 2a Platform Trial
collaborate with Foresee and look forward to evaluating the therapeutic potential of ALDH2 activation in PD" Dr. Simon Kverneng, MD, PhD, a neurology resident and experienced clinical researcher in Prof. Tzoulis' group, is the Principal Investigator of SLEIPNIR.Dr. Ben Chien,
More news about: Foresee Pharmaceuticals Co., Ltd.
Jun 07, 2026, 17:30 ET Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
bodyweight.4-6"The therapeutic potential of amylin in type 2 diabetes has been recognized by the medical community for many years," said John B. Buse, MD, PhD, Distinguished Professor of Medicine, Director of the UNC Diabetes Care Center. "Now, in the REIMAGINE trials, we're taking that knowledge forward by
More news about: NOVO NORDISK INC.
Jun 07, 2026, 16:45 ET Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
diabetes, one of the most immediate concerns is acute pancreatitis, which can lead to serious short- and long-term complications," said Yu Mi Kang, MD, PhD, MPH, a lead author of the study. "The presented findings suggest that olezarsen lowers the triglyceride levels and reduces the risk of pancreatitis
More news about: American Diabetes Association
Jun 07, 2026, 14:30 ET Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
drive meaningful improvements in overall metabolic health, and these findings are encouraging for potential new solutions," said Carel le Roux, MD, PhD, lead author of the study. "For patients, improving metabolic health is about more than weight loss alone, it can help reduce the risk of serious complications
More news about: American Diabetes Association
Jun 06, 2026, 14:30 ET Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
resulted in substantial weight reduction with nearly two thirds of participants reaching targets below the obesity threshold," said Ania M. Jastreboff, MD, PhD, professor at Yale, lead author of the study. "Importantly, in addition to significant weight reduction, treatment with retatrutide resulted in improvements
More news about: American Diabetes Association
Jun 06, 2026, 09:00 ET Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
obesity, especially because a once-monthly dosing could offer a more manageable alternative to today's more frequent injections," said John Buse, MD, PhD, lead author of the study. "For patients, this less frequent dosing may help ease the burden of ongoing treatment and support better long-term adherence
More news about: American Diabetes Association
Jun 05, 2026, 20:30 ET Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
saRNA Drives Durable, High-Quality Weight Loss in Diet-Induced Obese MicePoster Number: 3066-LBPresenter: Moorim Kang, PhD, Chief Technology OfficerDate/Time: Sunday, June 7, 2026, 12:30 PM - 1:30 PMLocation: Ernest N. Morial Convention Center,
More news about: Ractigen Therapeutics
Jun 05, 2026, 19:30 ET Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
type 2 diabetes by enabling earlier, more precise detection and supporting a more targeted, proactive approach to prevention," said Luis A. Rodriguez, PhD, MPH, RD, lead author of the study. "Our model has the potential to create an opportunity for clinicians and health systems to focus prevention efforts
More news about: American Diabetes Association
Jun 05, 2026, 18:30 ET First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control
significant advances in diabetes care, people living with type 1 diabetes continue to have limited treatment options beyond insulin," said Klara Klein, MD, PhD, lead author of the study. "These findings highlight the potential for the first incretin therapy developed specifically for type 1 diabetes to expand
More news about: American Diabetes Association
Jun 05, 2026, 09:00 ET Diakonos Oncology Shares Updated DOC1021 GBM Survival Data and Unveils Melanoma Clinical Study at ASCO 2026
dataset provides important insights into the clinical outcomes and immune responses observed with DOC1021 in glioblastoma," said Dr. Jay-Jiguang Zhu, MD, PhD, Study Investigator at UTHealth Houston (Department of Neurosurgery). "The findings, including the 12-month survival outcomes observed in a predominantly
More news about: Diakonos Oncology
Jun 04, 2026, 16:01 ET Businesses Are Paying Billions for Poor Community Health. A New Report Shows What They Can Do About It.
27 to 1 for national programs."Healthy communities are not separate from economic strength. They are the foundation of it," said Jean Accius, PhD, President & CEO of CHC: Creating Healthier Communities. "For too long, the cost of poor community health has been treated as someone else's problem,
More news about: Creating Healthier Communities
Jun 04, 2026, 14:00 ET What Happens When Success Stops Holding You Together? Sometimes the thing that helps us survive becomes the thing we eventually need to outgrow
author Lisa Feldman Barrett, PhD, neuroscientist and NYU Dean Wendy Suzuki, PhD, futures designer Nick Foster, RDI, sleep psychologist Jade Wu, PhD, broadcaster and author Krista Tippett, journalist and author Eliot Stein, medical anthropologist and author Theresa MacPhail, PhD, poet, activist, and author
More news about: Unlikely Collaborators
Jun 04, 2026, 12:22 ET Stanford University Libraries Welcome Two New Assistant University Librarians
Studies, and Social SciencesSussman started at the Libraries in 2002 as Curator of the French and Italian Collections soon after finishing her PhD in History at Stanford. During her tenure, she developed both the general and special collections in French and Italian focusing on women in France and
More news about: Stanford University Libraries